Supply and utilization of pediatric subspecialists in the United States

Kristin N Ray1, Debra L Bogen2, Marnie Bertolet3

  • 1Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; kristin.ray@chp.edu.

Pediatrics
|May 7, 2014
PubMed

Insights

Children in areas with fewer pediatric subspecialists utilize care less and perceive less need, but disease burden remains similar. This impacts access to essential pediatric subspecialty services.

Area of Science:

  • Pediatric healthcare access
  • Healthcare disparities
  • Subspecialty care utilization

Background:

  • Geographic variation in pediatric subspecialty supply is a significant concern in the US.
  • The impact of this variation on care utilization and patient outcomes is not well understood.
  • Children with special health care needs are particularly vulnerable to these disparities.

Purpose of the Study:

  • To examine the association between pediatric subspecialty supply and utilization, perceived need, and disease burden.
  • To investigate how geographic availability of pediatric subspecialists affects access to care for children with special health care needs.
  • To determine if lower subspecialty supply correlates with worse child or family disease burden.

Main Methods:

  • Utilized data from the 2009-2010 National Survey of Children With Special Health Care Needs.
  • Measured pediatric subspecialist supply as per capita rates at the county level.
  • Analyzed the association between supply quintiles and parent-reported outcomes, controlling for confounders.

Main Results:

  • Pediatric subspecialty supply varied widely, with some counties having zero specialists per 100,000 children.
  • Children in the lowest supply quintiles were significantly less likely to have ambulatory subspecialty visits and perceive care needs.
  • Conversely, those in low-supply areas had a higher likelihood of emergency department visits; no significant differences in overall disease burden were found.

Conclusions:

  • Lowest pediatric subspecialty supply areas show decreased utilization and perceived need for care.
  • Despite lower utilization, significant differences in child or family disease burden were not observed.
  • Findings highlight disparities in access to pediatric subspecialty care, underscoring the need for improved geographic distribution.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967